The 10th PhExFEST China Formulation Festival & 2026 Pharmaceutical Formulation Technology Symposium and Exhibition, hosted by the China Pharmaceutical Excipients Development Alliance, Anhui Pharmaceutical Industry Association and Anhui Pharmaceutical Packaging & Excipients Association, and organized by PHEXCOM, was successfully concluded at Shangri-La Hotel, Hefei, during October 15–17, 2026.

Uniting efforts for formulation innovation and empowering industrial upgrading. Rooted in the overarching goal of high-quality development of the pharmaceutical industry, this Formulation Festival closely followed the new landscape of pharmaceutical regulatory reform, emerging trends in formulation technology iteration, and new priorities of unmet clinical medication needs. Centered on the core tenets of innovation-driven development, quality-focused advancement and win-win integration, it built a professional, high-level industry platform integrating academic discussion, technical exchange, achievement exhibition, industrial matchmaking and standard co-development. The event brought together academicians, experts, representatives from research institutions, leading enterprises, regulatory authorities and upstream & downstream practitioners across the national pharmaceutical formulation chain. Multi-dimensional and in-depth exchanges were carried out to effectively address pain points in industrial development, streamline supply-demand links and consolidate consensus for industrial progress. All scheduled sessions were completed successfully, yielding fruitful academic and industrial outcomes.

The festival featured one main venue and three parallel sub-venues for in-depth discussions covering four key themes: regulatory policies for pharmaceutical formulations and excipients, development of high-end complex formulations, industry-academia-research translation of industrial pharmaceutics, and innovative formulation technologies for traditional Chinese medicine. It attracted approximately 650 delegates from more than 230 enterprises and research institutions nationwide, spanning pharmaceutical formulations, excipients, pharmaceutical equipment and analytical instruments. Participants covered the full spectrum of R&D, manufacturing, regulatory oversight and supporting services. Attendance scale, academic depth and industrial practical value all set new records for the series. The event fully demonstrates the strong momentum of solidarity and innovative breakthroughs within China’s pharmaceutical formulation sector, laying a solid foundation for further industrial upgrading in the next phase.